Biopharma company TetraGenetics grabs funding

Related Posts

22Feb

Blinded by rare disorder, Alberta man fundraising to regain vision

Now a new technology promises to lead him out of the dark. It's called eSight, electronic glasses for the legally... read more
12Feb

Advancing Platelet-Based Therapeutics for Patients

Platelet BioGenesis (PBG) reports that it is working with the Canadian Centre for Commercialization of Regenerative Medicine (CCRM) and GE... read more
22Nov

Myomo Announces Planned IPO

Myomo, a medical robotics company, has submitted a Form 1-A with the Securities and Exchange Commission regarding its proposes initial... read more
15Aug

Legally Blind North Texas Teen Receives $10K Glasses That Let Her See

A successful crowdfunding effort came together just in time, as a North Texas teen who is legally blind, will be... read more
01Mar

The 2022 Ballard Innovation Award Competition

Winter Innovations selected as a finalist. Read more >> read more
21Sep

Tax perks nudging employers to help pay workers’ student loans

By next year, many large companies will likely add that perk for their workers, after they’ve had time to amend... read more
23Oct

ZetrOZ Receives Funding from the National Institute of Health to Find New Ways to Reduce Arthritic Pain for Over 60 Million Americans Using Non-Narcotic, Non-Surgical Technology

ZetrOZ Systems, developers of sustained acoustic medicine (SAM), an FDA-cleared home-use ultrasound device that helps reduce pain associated with tendon,... read more
16Sep

Myomo Certified as Medicare Provider

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
13Sep

Stories that Inspire: Dr. Rahul Singh, Co-founder, EcoSoul Home

Discover how gifted entrepreneurs turned their dreams into reality! Join us for powerful mini-talks on chasing dreams, disrupting norms, and... read more
04Jan

Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd. ("Kaken")... read more